Published: July 17, 2022
Provepharm receives FDA approval for BLUDIGO™ (indigotindisulfonate sodium, USP) Injection
BLUDIGO™ is the first and only indigotindisulfonate sodium injection, USP, drug product approved by the FDA.
Published: July 17, 2022
BLUDIGO™ is the first and only indigotindisulfonate sodium injection, USP, drug product approved by the FDA.